Very hard to tell expected survival as some would have taken less chemo treatment and some more.
Based on 415 patients, that is roughly 10 chemo treatment. Folfiri allows maximum 12 treatment (from memory).
As for Fonda numbers, I was really expecting a lower number based on last years figures. Percentage wise, it is higher than last year, ACL should have just put that percentage comparing last year. Maybe they were waiting for the DSMB recommendation to offset disappointment with Fonda figure.
- Forums
- ASX - By Stock
- TSN
- Ann: Fondaparinux Investor Update
Ann: Fondaparinux Investor Update , page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable